Dipna Pharmachem Share Price
3.90+0.02 (-5.80%)
-76.91% past 1 Year
Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.
Price Analysis
About
Stock Analysis (SWOT)
QVT
Peer Stocks
1 week
1 month
1 year
Name
ADANIENT-ANSE
CPPLUS-ANSE
AEGISLOG-ANSE
PREMIERENE-ANSE
REDINGTON-ANSE
HONASA-ANSE
LLOYDSENT-ANSE
CELLO-ANSE
JSLL-ANSE
SREEL-TNSE
DPL-MNSE
Dipna Pharmachem Share Price
3.90+0.02 (-5.80%)
-76.91% past 1 Year
Financial overview
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
CAGR%
Sales
Profits
Returns
ROE
| 10Y | 5Y | 3Y | TTM |
|---|---|---|---|
| - | 33% | 20% | -24% |
| - | 75% | -6% | -10% |
| - | - | -32% | -77% |
| 19% | 24% | 4% | 3% |
Peer Comparison
Symbol
ADANIENT-A
CPPLUS-A
AEGISLOG-A
PREMIERENE-A
REDINGTON-A
HONASA-A
LLOYDSENT-A
CELLO-A
JSLL-A
SREEL-T
DPL-M
| Price | M.Cap (₹) | PE Ratio | EPS (₹) | EV/EBITDA | Annual PAT |
|---|---|---|---|---|---|
| 2,710 | ₹365234 Cr | 63.65 | 11.02 | 97.19 | ₹9339 Cr |
| 4,033.8 | ₹49371 Cr | 83.28 | 15.13 | 53.43 | ₹368 Cr |
| 1,189.75 | ₹44400 Cr | 33.33 | 7.42 | 40.69 | ₹898 Cr |
| 838 | ₹37723 Cr | 21.32 | 10.09 | 46.95 | ₹1510 Cr |
| 331.5 | ₹26682 Cr | 14.39 | 6.92 | 26.4 | ₹1490 Cr |
| 527.25 | ₹17272 Cr | 61.09 | 2.24 | 9.99 | ₹200 Cr |
| 61.03 | ₹9779 Cr | 95.38 | 0.09 | 0.89 | ₹283 Cr |
| 369.75 | ₹8198 Cr | 26.53 | 3.63 | 17.5 | ₹332 Cr |
| 299.25 | ₹3765 Cr | 17.56 | 2.95 | 22.03 | ₹222 Cr |
| 263 | ₹637 Cr | 18.69 | 4.27 | 15.29 | ₹29 Cr |
| 3.9 | ₹11 Cr | 4.14 | 0.15 | 1.01 | ₹3 Cr |
Profit & Loss
Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
| Jun 2026 | Mar 2026 | Jun 2025 | Mar 2025 |
|---|---|---|---|
| ₹24 Cr | ₹2 Cr | ₹19 Cr | ₹16 Cr |
| ₹24 Cr | ₹2 Cr | ₹19 Cr | ₹16 Cr |
| ₹23 Cr | ₹2 Cr | ₹18 Cr | ₹15 Cr |
| ₹83 L | ₹46 L | ₹73 L | ₹1 Cr |
| ₹31 L | ₹23 L | ₹16 L | ₹60 L |
| ₹53 L | ₹22 L | ₹57 L | ₹68 L |
| ₹40 L | ₹18 L | ₹57 L | ₹50 L |
Balance Sheet
Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Secured Loans
Unsecured Loans
Deferred Tax Assets / Liabilities
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Total Non-Current Assets
Current Assets Loans & Advances
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
| Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 |
|---|---|---|---|---|---|---|---|
| — | — | — | — | — | — | — | — |
| ₹24 Cr | ₹24 Cr | ₹12 Cr | ₹4 L | ₹4 L | ₹4 L | ₹4 L | ₹4 L |
| ₹14 Cr | ₹13 Cr | ₹12 Cr | ₹2 Cr | ₹54 L | ₹51 L | ₹45 L | ₹42 L |
| ₹14 Cr | ₹13 Cr | ₹12 Cr | ₹2 Cr | ₹54 L | ₹51 L | ₹45 L | ₹42 L |
| ₹38 Cr | ₹38 Cr | ₹24 Cr | ₹2 Cr | ₹57 L | ₹55 L | ₹49 L | ₹46 L |
| ₹7 Cr | ₹11 Cr | ₹9 Cr | ₹22 L | ₹30 L | ₹8 L | ₹0 | ₹0 |
| ₹1 Cr | ₹2 Cr | ₹2 Cr | ₹6 Cr | ₹3 Cr | ₹3 Cr | ₹0 | ₹0 |
| -₹29,000 | -₹25,000 | -₹6,000 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹9 Cr | ₹13 Cr | ₹11 Cr | ₹6 Cr | ₹4 Cr | ₹3 Cr | ₹0 | ₹0 |
| — | — | — | — | — | — | — | — |
| ₹76 Cr | ₹75 Cr | ₹36 Cr | ₹23 Cr | ₹12 Cr | ₹8 Cr | ₹8 Cr | ₹5 Cr |
| ₹40 L | ₹20 L | ₹14 L | ₹87 L | ₹41,000 | ₹1 L | ₹2 L | ₹3 L |
| ₹8 Cr | ₹7 Cr | ₹5 Cr | ₹4 Cr | ₹9 Cr | ₹6 Cr | ₹6 Cr | ₹5 Cr |
| ₹54 L | ₹1 Cr | ₹87 L | ₹40 L | ₹1 L | ₹0 | ₹2 L | ₹0 |
| ₹85 Cr | ₹83 Cr | ₹42 Cr | ₹29 Cr | ₹21 Cr | ₹15 Cr | ₹14 Cr | ₹11 Cr |
| ₹132 Cr | ₹133 Cr | ₹78 Cr | ₹36 Cr | ₹25 Cr | ₹18 Cr | ₹14 Cr | ₹11 Cr |
| ₹17 Cr | ₹19 Cr | ₹16 Cr | ₹10 Cr | ₹12 Cr | ₹10 Cr | ₹6 Cr | ₹5 Cr |
| — | — | — | — | — | — | — | — |
| ₹13 L | ₹11 L | ₹9 L | ₹8 L | ₹7 L | ₹7 L | ₹7 L | ₹1 L |
| ₹8 L | ₹7 L | ₹5 L | ₹4 L | ₹3 L | ₹3 L | ₹2 L | ₹75,574 |
| ₹5 L | ₹4 L | ₹4 L | ₹4 L | ₹4 L | ₹4 L | ₹5 L | ₹51,276 |
| ₹5 L | ₹4 L | ₹4 L | ₹4 L | ₹4 L | ₹4 L | ₹5 L | ₹51,276 |
| — | — | — | — | — | — | — | — |
| ₹27 Cr | ₹37 Cr | ₹19 Cr | ₹6 Cr | ₹7 Cr | ₹6 Cr | ₹3 Cr | ₹4 Cr |
| ₹46 Cr | ₹31 Cr | ₹29 Cr | ₹27 Cr | ₹15 Cr | ₹11 Cr | ₹9 Cr | ₹6 Cr |
| ₹43 L | ₹14 Cr | ₹6 Cr | ₹21 L | ₹25 L | ₹18 L | ₹12 L | ₹30 L |
| ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹78,000 | ₹0 | ₹0 |
| ₹58 Cr | ₹51 Cr | ₹24 Cr | ₹3 Cr | ₹2 Cr | ₹1 Cr | ₹2 Cr | ₹44 L |
| ₹132 Cr | ₹133 Cr | ₹78 Cr | ₹36 Cr | ₹25 Cr | ₹18 Cr | ₹14 Cr | ₹11 Cr |
| ₹47 Cr | ₹50 Cr | ₹35 Cr | ₹7 Cr | ₹4 Cr | ₹4 Cr | ₹44 L | ₹45 L |
| ₹132 Cr | ₹133 Cr | ₹78 Cr | ₹36 Cr | ₹25 Cr | ₹18 Cr | ₹14 Cr | ₹11 Cr |
| ₹16 | ₹16 | ₹20 | ₹497 | ₹163 | ₹156 | ₹140 | ₹130 |
| ₹16 | ₹16 | ₹17 | ₹85 | ₹34 | ₹33 | ₹29 | ₹27 |
Cash Flow
Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Closing Cash & Cash Equivalent
| Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 |
|---|---|---|---|---|---|---|---|
| ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹2 Cr | ₹6 L | ₹6 L | ₹0 | ₹0 |
| ₹2 Cr | ₹2 Cr | ₹97 L | ₹61 L | ₹35 L | ₹39 L | ₹0 | ₹0 |
| -₹12 Cr | -₹9 Cr | -₹23 Cr | ₹1 Cr | -₹3 Cr | -₹4 Cr | ₹0 | ₹0 |
| -₹9 Cr | -₹5 Cr | -₹21 Cr | ₹3 Cr | -₹2 Cr | -₹3 Cr | ₹0 | ₹0 |
| -₹9 Cr | -₹5 Cr | -₹21 Cr | ₹3 Cr | -₹2 Cr | -₹3 Cr | ₹0 | ₹0 |
| -₹2 L | -₹1 L | -₹1 L | -₹67,712 | ₹44,000 | ₹83,000 | ₹0 | ₹0 |
| -₹4 Cr | ₹14 Cr | ₹26 Cr | -₹3 Cr | ₹3 Cr | ₹3 Cr | ₹0 | ₹0 |
| -₹13 Cr | ₹8 Cr | ₹5 Cr | -₹4 L | ₹8 L | ₹6 L | ₹0 | ₹0 |
| ₹14 Cr | ₹6 Cr | ₹21 L | ₹25 L | ₹18 L | ₹12 L | ₹0 | ₹0 |
| ₹43 L | ₹14 Cr | ₹6 Cr | ₹21 L | ₹25 L | ₹18 L | ₹0 | ₹0 |
Fundamental Ratios
Consolidated
Standalone

No results found
Dipna Pharmachem Share Price
3.90+0.02 (-5.80%)
-76.91% past 1 Year
Technical meters
Oscillators
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 3
Bearish signals: 5 out of 9 oscillators
RSI
42.13Sell
STOCH %K
12.35Buy
MACD Level(12,26)
-0.04Sell
Ultimate Oscillator
45.47Sell
Aroon Oscillator
-68.00Sell
BOP
-0.43Sell
CCI
-48.94Neutral
Williams %R
-87.65Buy
Momentum
0.08Buy
Moving averages
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 0
Bearish signals: 9 out of 9 moving averages
EMA 9
4.09Sell
SMA 9
4.15Sell
EMA 21
4.12Sell
SMA 21
4.05Sell
EMA 50
4.37Sell
SMA 50
4.24Sell
EMA 200
7.71Sell
SMA 200
7.18Sell
WMA 20
4.12Sell
Pivot
Pivot
Classic
Resistance 5
5.00
Resistance 4
4.78
Resistance 3
4.56
Resistance 2
4.34
Resistance 1
4.24
Pivot
4.12
Support 1
4.02
Support 2
3.90
Support 3
3.68
Support 4
3.46
Support 5
3.24
High & lows
1 Day
1 Week
1 Month
3 Months
6 Months
Year to Date
1 Year
3 Years
5 Years
10 Years
All Time
Dipna Pharmachem Share Price
3.90+0.02 (-5.80%)
-76.91% past 1 Year
Shareholding summary
Shareholding Pattern
Quarterly
Yearly
Name
Promoters
FII
DII - Others
DII - MFs
Retail & Others
| Sep 2026 | Jun 2026 | Mar 2026 | Sep 2025 | Mar 2025 | Sep 2024 |
|---|---|---|---|---|---|
| 9.13% | 9.13% | 9.13% | 9.98% | 9.98% | 9.98% |
| 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 90.87% | 90.87% | 90.87% | 90.02% | 90.02% | 90.02% |
Bulk & block deals
Name
Hriday Aatish Shah
Neerita Sanjay Jain
Sanjay Nirmal Jain Huf
Namita Hemant Jain
Namita Hemant Jain
Hemant Naresh Jain Huf
Hemant Naresh Jain Huf
Kalpalabdhi Securities Private Limited
Namita Hemant Jain
Kalpalabdhi Securities Private Limited
| Deal Date | Action | Deal Value | Deal Price | Qty Traded | Deal Type | %Stake Traded | Exchange |
|---|---|---|---|---|---|---|---|
| 14 Aug 2026 | Purchase | 8.55 L | ₹5.70 | 1.50 L | Bulk | 0.570577 | BSE |
| 04 Aug 2026 | Sell | 12.18 L | ₹4.10 | 2.97 L | Bulk | 1.129741 | BSE |
| 04 Aug 2026 | Sell | 11.98 L | ₹4.39 | 2.73 L | Bulk | 1.038449 | BSE |
| 27 Jul 2026 | Sell | 7.52 L | ₹4.25 | 1.77 L | Bulk | 0.67328 | BSE |
| 07 Jul 2026 | Sell | 8.66 L | ₹5.55 | 1.56 L | Bulk | 0.5934 | BSE |
| 01 Jul 2026 | Sell | 7.77 L | ₹5.89 | 1.32 L | Bulk | 0.502107 | BSE |
| 26 May 2026 | Sell | 10.40 L | ₹7.22 | 1.44 L | Bulk | 0.547753 | BSE |
| 21 Nov 2025 | Sell | 40.03 L | ₹16.89 | 2.37 L | Bulk | 0.985644 | BSE |
| 21 Nov 2025 | Purchase | 40.46 L | ₹16.86 | 2.40 L | Bulk | 0.99812 | BSE |
| 20 Nov 2025 | Sell | 50.25 L | ₹15.51 | 3.24 L | Bulk | 1.347462 | BSE |
Insider trading & SAST
Client name
| Reported on | Client category | Action | %Stake traded | Holding % post deal | Deal value | Deal price | Qty traded | Deal period | Deal mode | Post transaction holding | Insider/SAST | Regulation type | Security type |
|---|
Dipna Pharmachem Share Price
3.90+0.02 (-5.80%)
-76.91% past 1 Year
Dipna Pharmachem Limited is engaged in the trading and distribution of wide range of pharmaceutical raw material which is also known as APIs (Active Pharmaceutical Ingredients), Excipient and chemical formulation
Corporate Actions
Date
Type
Details
Company details
Dipna Pharmachem Share Price
3.90+0.02 (-5.80%)
-76.91% past 1 Year
Corporate filings & documents
Announcements
Annual reports
Concalls & investor presentations
Dipna Pharmachem Share Price
3.90+0.02 (-5.80%)
-76.91% past 1 Year
News
1 of 20
ResultDPL29 Jun 2026
NULL
Dipna Pharmachem informs about clarification sought on significant movement in price
Stock NewsDPL21 Jan 2026
NULL
Dipna Pharmachem informs about outcome of board meeting
Stock NewsDPL29 Nov 2025
NULL
Dipna Pharma. reports Profit after tax of 1.41 Crores, in the September 2025 quarter
ResultDPL26 Nov 2025
NULL
Dipna Pharmachem informs about rescheduling of board meeting
Stock NewsDPL19 Nov 2025
NULL
Dipna Pharmachem informs about updates
Stock NewsDPL18 Apr 2024
NULL
Dipna Pharmachem informs about disclosure
Stock NewsDPL18 Apr 2024
NULL
Dipna Pharmachem informs about updates
Stock NewsDPL2 Apr 2024
NULL
Dipna Pharmachem informs about press release
Stock NewsDPL20 Mar 2024
NULL
Dipna Pharmachem informs about newspaper advertisement
Stock NewsDPL16 Mar 2024
NULL
Dipna Pharmachem informs about outcome of board meeting
Stock NewsDPL15 Mar 2024
NULL
Dipna Pharmachem informs about newspaper advertisement
Stock NewsDPL21 Feb 2024
NULL
Dipna Pharmachem submits intimation of in-principle approval for rights issue
Stock NewsDPL18 Jan 2024
NULL
Dipna Pharmachem informs about disclosures
Stock NewsDPL27 Dec 2023
NULL
Dipna Pharmachem informs about appointment of CS cum CO
Stock NewsDPL16 Dec 2023
NULL
Dipna Pharmachem informs about disclosure
Stock NewsDPL15 Dec 2023
NULL
Dipna Pharmachem informs about EGM
Stock NewsDPL11 Dec 2023
NULL
Dipna Pharmachem informs about disclosure
Stock NewsDPL11 Dec 2023
NULL
Dipna Pharmachem informs about outcome of board meeting
Stock NewsDPL8 Dec 2023
NULL
Dipna Pharmachem informs about disclosures
Stock NewsDPL7 Dec 2023
NULL

